Longshoremen, plastic surgeons, community health centers among winners in Senate health bill
LOSERS
Generic drug makers. They fought unsuccessfully to block 12 years of protection that makers of brand-name biotech drugs -- expensive pharmaceuticals made from living cells -- will get against generic would-be competitors.
How can you describe the Senate bill as a win for health insurers when it contains a hard limit on the allowable medical loss ratio?
I’d like to hear zipjet’s opinion on this; my initial reaction to this provision of the Senate bill was that it could be construed as a violation of the due process clause in the US Constitution.
Market Data 
Markets 
AI
